Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain

Journal of Thrombosis and Haemostasis

Volumn 11, Issue 8, 2013, Pages 1519-1526

  Yang, L ^a   Vuylsteke, A ^b   Gerrard, C ^b   Besser, M ^a   Baglin, T ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Fibrinogen; Hemorrhage; Hemostasis; Therapy; Thoracic surgery

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE;

AGED; ARTICLE; CORRELATION ANALYSIS; CRYOPRECIPITATE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTITUTION THERAPY; THORAX SURGERY;

FIBRINOGEN; HEMORRHAGE; HEMOSTASIS; THERAPY; THORACIC SURGERY;

AGED; CARDIAC SURGICAL PROCEDURES; DATABASES, FACTUAL; FEMALE; FIBRINOGEN; HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; THROMBIN TIME; TREATMENT OUTCOME;

EID: 84881588539     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12304     Document Type: Article

References (19)

1. Ehmann WC, Al-Mondhiry H. Congenital afibrinogenemia and splenic rupture. Am J Med 1994; 96: 92-4.
2. Shima M, Tanaka I, Sawamoto Y, Kanehiro H, Matsuo N, Nishimura A, Giddings JC, Yoshioka A. Successful treatment of two brothers with congenitala fibrinogenemia for splenic rupture using heat- and solvent detergent-treated fibrinogen concentrates. Pediatr Hematol Oncol 1997; 19: 462-5.
3. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28.
4. Haas T, Fries D, Velik-Salchner C, Oswald E, Innerhofer P. Fibrinogen in craniosynostosis surgery. Anesth Analg 2008; 106: 725-31.
5. Moganasundram S, Hunt BJ, Sykes K, Holton F, Parmar K, Durward A, Murdoch IA, Austin C, Anderson D, Tibby SM. The relationship among thromboelastography, hemostatic variables, andbleeding after cardiopulmonary bypass surgery in children. Anesth Analg 2010; 110: 995-1002.
6. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008; 48: 2152-8.
7. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Stahel PF, Vincent JL, Spahn DR. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010; 14: R52.
8. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, De Prost D. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73.
9. Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, Carrico CJ. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67: 365-8.
10. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-51.
11. Besser MW, Klein AA. The coagulopathy of cardiopulmonary bypass. Crit Rev Clin Lab Sci 2010; 47: 197-212.
12. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P, Saggau W. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005; 93: 1101-7.
13. Vuylsteke A, Pagel C, Gerrard C, Reddy B, Nashef S, Aldam P, Utley M. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 2011; 39: 924-30.
14. Rothnie NG. Abnormal bleeding after total body perfusion. Ann R Coll Surg Engl 1961; 29: 102-12.
15. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102: 137-44.
16. French CJ, Bellomo R, Angus P. Cryoprecipitate for the correction of coagulopathy associated with liver diseaseAnaesth Intensive Care 2003; 31: 357-61.
17. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, Sorensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7: 795-802.
18. Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res 2010; 126: e428-33.
19. Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010; 149: 834-43.